The level of anti-viral antigen-specific antibodies to EBNA-1 in the serum of ms patients does not depend on the severity of the disease
- 作者: Ovchinnikova L.А.1, Dzhelad S.S.1, Simaniv Т.О.2, Zakharova М.N.2, Gabibov А.G.1,3, Lomakin Y.A.1
-
隶属关系:
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS
- Research Center of Neurology
- Lomonosov Moscow State University
- 期: 卷 515, 编号 1 (2024)
- 页面: 92-96
- 栏目: Articles
- URL: https://rjpbr.com/2686-7389/article/view/651449
- DOI: https://doi.org/10.31857/S2686738924020174
- EDN: https://elibrary.ru/WEJGMJ
- ID: 651449
如何引用文章
详细
Multiple sclerosis (MS) is an autoimmune neurodegenerative disease leading to inevitable disability and primarily affecting the young and middle-aged population. Recent studies have shown a direct correlation between the risk of MS development and Epstein-Barr virus (EBV) infection. Analysis of the titer of EBV-specific antibodies among patients with MS and healthy donors among Russian population confirmed that MS is characterized by an increased level of serum IgG binding EBNA-1 (EBV nuclear antigen 1). The number of patients with elevated levels of EBNA-1-specific antibodies does not differ statistically significantly between two groups with diametrically opposite courses of MS: benign MS or highly active MS. It can be assumed that the primary link between EBV and the development of MS is restricted to the initiation of the disease and does not impact its severity.
全文:

作者简介
L. Ovchinnikova
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS
Email: gabibov@gmail.com
俄罗斯联邦, Moscow
S. Dzhelad
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS
Email: gabibov@gmail.com
俄罗斯联邦, Moscow
Т. Simaniv
Research Center of Neurology
Email: gabibov@gmail.com
俄罗斯联邦, Moscow
М. Zakharova
Research Center of Neurology
Email: gabibov@gmail.com
俄罗斯联邦, Moscow
А. Gabibov
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS; Lomonosov Moscow State University
编辑信件的主要联系方式.
Email: gabibov@gmail.com
Academician
俄罗斯联邦, Moscow; MoscowYa. Lomakin
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS
Email: yasha.l@bk.ru
俄罗斯联邦, Moscow
参考
- Baecher-Allan C., Kaskow B.J., Weiner H.L. Multiple sclerosis: mechanisms and immunotherapy // Neuron. 2018a. Т. 97. № 4. С. 742–768.
- Bjornevik K. и др. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis // Science. 2022b. Т. 375. № 6578. С. 296–301.
- Lomakin Y. и др. Exposure to the Epstein-Barr Viral Antigen Latent Membrane Protein 1 Induces Myelin-Reactive Antibodies In Vivo // Front. Immunol. 2017c. Т. 8. С. 777.
- Jons D. и др. Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage // J. Neurol. Neurosurg. Psychiatr. 2023d.
- Liu M., Wang R., Xie Z. T cell-mediated immunity during Epstein-Barr virus infections in children // Infect. Genet. Evol. 2023e. Т. 112. С. 105443.
- Kang M.-S., Kieff E. Epstein-Barr virus latent genes // Exp. Mol. Med. 2015f. Т. 47. № 1. С. e131.
- Lanz T.V. и др. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM // Nature. 2022g. Т. 603. № 7900. С. 321–327.
- Lomakin Y.A. и др. Multiple Sclerosis Is Associated with Immunoglobulin Germline Gene Variation of Transitional B Cells // Acta Naturae. 2022h. Т. 14. № 4. С. 84–93.
- Lomakin Y.A. и др. Deconvolution of B cell receptor repertoire in multiple sclerosis patients revealed a delay in tBreg maturation // Front. Immunol. 2022i. Т. 13. С. 803229.
- Correale J., Ysrraelit M.C., Fiol M.P. Benign multiple sclerosis: does it exist? // Curr. Neurol. Neurosci. Rep. 2012j. Т. 12. № 5. С. 601–609.
- Díaz C., Zarco L.A., Rivera D.M. Highly active multiple sclerosis: An update // Mult. Scler. Relat. Disord. 2019k. Т. 30. С. 215–224.
- Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) // Neurology. 1983l. Т. 33. № 11. С. 1444–1452.
补充文件
